R&D News | pharmaphorum

News

AI specialist Intelligent Omics bags J&J deal

UK artificial intelligence (AI) specialist Intelligent Omics has entered into a research collaboration with Johnson & Johnson, within weeks of joining the big pharma's

News

Sanofi names VC leader Houman Ashrafian as R&D chief

Sanofi has made an interesting choice for its new head of R&D, turning to Houman Ashrafian, who has deep expertise in the biopharma industry, but can also draw on his

News

Novo Nordisk buys another obesity biotech

Novo Nordisk has agreed its second acquisition in the space of a month of a biotech in the obesity category, snapping up fellow Danish company Embark Biotech for €15 milli

News

FibroGen slumps on second failed DMD study

FibroGen has revealed that a second late-stage clinical trial of Duchenne muscular dystrophy (DMD) therapy pamrevlumab has failed to show efficacy, extending a run of bad

News

Poll finds UK pharma's rep still high post-COVID

The UK pharma industry saw a spike in public trust and favourability amid the COVID-19 pandemic that, so far, shows little sign of wearing off, according to a new poll.

News

Google builds in biotech AI with Ginkgo alliance

Google Cloud and Ginkgo Bioworks have started a five-year partnership to bring artificial intelligence to biotech in areas including genomics, protein studies, and infecti

AI specialist Intelligent Omics bags J&J deal

Sanofi names VC leader Houman Ashrafian as R&D chief

Novo Nordisk buys another obesity biotech

FibroGen slumps on second failed DMD study

Poll finds UK pharma's rep still high post-COVID

Google builds in biotech AI with Ginkgo alliance

FDA grants three priority vouchers to psychedelics

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks